Dedicated to advancing neurointerventional therapies for stroke

ABOUT NEURAVI   |   Led by a team experienced in endovascular device development and global commercialization, the company’s initial technology platform addresses acute ischemic stroke. In collaboration with international researchers and clinicians, the company seeks to develop new understanding that will drive innovative solutions to treat this challenging and devastating disease.

Neuravi Thromboembolic Initiative

Interdisciplinary collaboration to further understanding of thromboembolic mechanics

Learn more →


The EmboTrap® Revascularization Device is a new minimally invasive platform for treating acute ischemic stroke

Learn more →

Clinical Studies

Neuravi is committed to developing clinical data to advance the treatment of stroke

Learn more →

Latest News

Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever

Learn more →